{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-103164","form_type":"8-K","ticker":"MRKR","cik":"0001094038","company_name":"Marker Therapeutics, Inc.","filed_at":"2022-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.967017+00:00","generated_at":"2026-06-23T07:09:35.673420+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Marker Therapeutics CFO Anthony Kim to depart Sept 30 as part of capital conservation measures","bullets":["CFO Anthony Kim separated effective September 30, 2022; part of company's capital conservation measures.","Severance benefits provided consistent with his Employment Agreement upon signing release.","No successor named; CEO Peter Hoang remains.","Company implementing cost-saving measures; CFO exit follows prior cost reduction steps."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-103164","json":"https://secwatch.observer/filing/0001104659-22-103164.json","markdown":"https://secwatch.observer/filing/0001104659-22-103164.md","text":"https://secwatch.observer/filing/0001104659-22-103164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1094038/000110465922103164/0001104659-22-103164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1094038/000110465922103164/tm2226666d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T07:09:35.673420+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c6afa22d2","claim":"Anthony Kim departed as Chief Financial Officer at Marker Therapeutics, Inc..","evidence_excerpt":"Marker Therapeutics, Inc. (the “ Company ”) previously announced that the Company had separated Anthony Kim, Chief Financial Officer of the Company, effective September 30, 2022, as part of the Company’s capital conservation measures.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465922103164/0001104659-22-103164-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}